Glioma Clinical Trials in Los Angeles

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Glioma
  • Recurrent Malignant Glioma
  • Los Angeles, California
  • +15 more
2022-03-04
Mar 4, 2022
J
Active, not recruiting
  • Glioma
  • +3 more
  • autologous tumor lysate-pulsed DC vaccination
  • +2 more
  • Los Angeles, California
    University of Los Angeles, California
2022-02-16
Feb 16, 2022
E
Recruiting
  • Cholangiocarcinoma
  • +3 more
  • Phoenix, Arizona
  • +33 more
2022-02-15
Feb 15, 2022
P
Active, not recruiting
  • Glioma
  • Los Angeles, California
  • +9 more
2022-02-11
Feb 11, 2022
I
Active, not recruiting
  • Glioma
  • Los Angeles, California
  • +5 more
2022-02-10
Feb 10, 2022
C
Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
2021-11-18
Nov 18, 2021
J
Recruiting
  • Glioma
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2021-09-24
Sep 24, 2021
I
Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Scottsdale, Arizona
  • +11 more
2021-08-17
Aug 17, 2021
D
Completed
  • Brain Cancer
  • +10 more
  • DNX-2401
  • pembrolizumab
  • Little Rock, Arkansas
  • +14 more
2021-07-13
Jul 13, 2021
U
Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +19 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
2021-03-15
Mar 15, 2021
J
Completed
  • Glioma
  • Glioblastoma
  • FDOPA PET/CT
  • Los Angeles, California
    UCLA
2020-07-23
Jul 23, 2020
J
Withdrawn
  • Glioblastoma
  • Glioma
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2020-07-22
Jul 22, 2020
N
Completed
  • Glioblastoma Multiforme
  • +3 more
  • Castro Valley, California
  • +16 more
2020-05-26
May 26, 2020
U
Completed
  • Glioma
  • RAD001 (Everolimus)
  • Los Angeles, California
  • +11 more
2020-01-31
Jan 31, 2020
D
Terminated
  • Glioblastoma Multiforme
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • +3 more
  • Los Angeles, California
  • +4 more
2019-11-12
Nov 12, 2019
C
Terminated
  • Glioma
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
2017-09-08
Sep 8, 2017
D
Completed
  • Glioblastoma
  • +2 more
  • Trans Sodium Crocetinate (TSC)
  • Phoenix, Arizona
  • +17 more
2017-06-16
Jun 16, 2017
S
Completed
  • Brain Cancer
  • +3 more
  • [18F]FHBG
  • Los Angeles, California
  • +1 more
2017-03-12
Mar 12, 2017
N
Unknown status
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
2016-10-12
Oct 12, 2016
B
Completed
  • Glioma
  • Los Angeles, California
  • +1 more
2016-04-04
Apr 4, 2016
R
Completed
  • Glioma
  • RTA 744
  • RTA 744 injection
  • Los Angeles, California
  • +3 more
2014-11-05
Nov 5, 2014